Mr. Speaker, many of us, of our friends or relatives are living in hope that new medications will be found to treat the disease they suffer from.
New drugs that are the outcome of research must, however, go through an entire system of review and approval before they can be marketed.
Unfortunately, however, the deadlines for approval are not always met, for a variety of reasons, the consequence of which is intense worries for a number of patients.
One of the ways of attaining this objective is to create a mechanism to ensure that the deadlines for new drug approvals are really improved and adhered to.
Finally, all stakeholders must work together in the patients' interest.